Sign in Create account

Amanta Healthcare Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: AMANTA BSE: 544502
₹199.92
▲ 9.52 (5.00%)
Oct. 5, 2026 · NSE · nse_bhavcopy
Quality
48/100
Moderate
Valuation
25/100
Expensive
Momentum
54/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹776 Cr
PE (TTM)
48.1
Industry median 35.6 (152 companies)
Price to Book
3.5
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
13.35%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
28.3
Relative return vs Sector, qtr %
18.6
Free Cash Flow
₹-32 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-30.33%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
5.35%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.69
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
1.06
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
2.01
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
7.18%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
15.26%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
14.13%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
Data unavailable.
Return on Capital Employed
10.04%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 3 met
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (1.06)
  • Yes Net cash flow for the latest year is positive

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 2 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median

Value and momentum

2 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
5.0%
Low 195.0000 · High 199.9200
1W return
9.2%
Low 179.3400 · High 199.9200
1M return
3.0%
Low 179.3400 · High 209.9500
52W return
45.1%
Low 92.0000 · High 209.9500
Lifetime High ₹205.8900 (Sept. 9, 2026)
Lifetime Low ₹95.0300 (March 17, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish6
Bearish0
5D
192.4
10D
190.9
20D
189.9
50D
182.4
100D
167.6
200D
138.0

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

198.28
Pivot
First resistance201.56
Second resistance203.20
Third resistance206.48
First support196.64
Second support193.36
Third support191.72
Day RSI62.5
Day MFI64.9
Day MACD1.92
Day MACD signal2.21

Beta

1M0.47
3M0.10
1Y0.74
3Y0.75

Price change analysis

↑ 3.0%
Over 1 Month
LowHigh
179.34209.95
↑ 16.7%
Over 3 Months
LowHigh
150.01209.95
↑ 86.6%
Over 6 Months
LowHigh
104.61209.95
↑ 45.1%
Over 1 Year
LowHigh
92.00209.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 48.1 (own history: 22.0–38.7)
Overvalued (above its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹69 Cr
Net profit (June 30, 2026)
₹3 Cr
Basic EPS (June 30, 2026)
₹0.8500

Ranks #96 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter63.80%
  • Mutual funds5.33%
  • FII/FPI0.43%
  • Other DII7.59%
  • Public22.85%

Largest holders

NameCategoryShares %Shares
Bhavesh Girishbhai PatelPromoter16.3100%6332179
Vishal Ashokkumar PatelPromoter10.0600%3905288
Jitendrakumar Jashbhai PatelPromoter9.0200%3502038
Milcent Appliances Private LimitedPromoter7.9800%3100000
Praful Jashbhai PatelPromoter5.8800%2282264

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 63.72% to 63.80% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 0.85% to 0.43% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 5.09% to 5.33% in Jun 2026 qtr

2 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 2 SAST, 0 pledge events →

All insider and SAST disclosures →

Deals (Bulk & Block)

All 18 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
11 Jun 2026 SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED Bulk Buy 262,235 159.0400 NSE
11 Jun 2026 SILVERLEAF CAPITAL SERVICES PRIVATE LIMITED Bulk Sell 262,235 158.8500 NSE
11 Jun 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 380,749 156.2400 NSE
11 Jun 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 380,749 156.0700 NSE
11 Jun 2026 BLITZQUANT RESEARCH LLP Bulk Sell 205,983 158.9600 NSE
11 Jun 2026 BLITZQUANT RESEARCH LLP Bulk Buy 205,983 158.8500 NSE
11 Jun 2026 ALPHAGREP SECURITIES PRIVATE LIMITED Bulk Buy 218,854 156.5600 NSE
11 Jun 2026 ALPHAGREP SECURITIES PRIVATE LIMITED Bulk Sell 218,854 156.3500 NSE
16 Apr 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Sell 216,504 124.8600 NSE
16 Apr 2026 MANSI SHARE AND STOCK BROKING PRIVATE LIMITED Bulk Buy 216,504 123.0900 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
5 Aug 2026 Financial Results Yes
19 May 2026 Financial Results Yes
10 Feb 2026 Financial Results Yes
11 Nov 2025 Financial Results Yes
26 Sep 2025 Other business matters —

Corporate Announcements

All 99 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
5 Oct 2026 Insider Trading / SAST Amanta Healthcare Ltd - 544502 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
1 Oct 2026 Company Update Amanta Healthcare Ltd - 544502 - Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares
1 Oct 2026 Insider Trading / SAST Amanta Healthcare Ltd - 544502 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
1 Oct 2026 Updates Amanta Healthcare Limited has informed the Exchange regarding 'Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of InsiderTrading) Regulations, 2015'.
30 Sep 2026 Company Update Amanta Healthcare Ltd - 544502 - Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares
30 Sep 2026 Insider Trading / SAST Amanta Healthcare Ltd - 544502 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
30 Sep 2026 Updates Amanta Healthcare Limited has informed the Exchange regarding ''Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of InsiderTrading) Regulations, 2015'.'.
24 Sep 2026 Trading Window Amanta Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
16 Sep 2026 AGM/EGM Amanta Healthcare Ltd - 544502 - Shareholder Meeting / Postal Ballot-Outcome of AGM
16 Sep 2026 AGM/EGM Amanta Healthcare Ltd - 544502 - Shareholder Meeting - Scrutinizer''''s Report

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.69)

Weaknesses

  • High financial leverage (Debt/Equity 1.06)

Opportunities

Data unavailable.

Threats

  • PE above 35 (48.1) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Amanta Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.